Long Shortz with Aroa Biosurgery: Unlocking regenerative healing through ECM technology

Tylah Tully speaks with Aroa Biosurgery (ASX:ARX) senior medical science liaison Dr Brandon Bosque about how Aroa’s groundbreaking ECM technology, backed by 100 peer-reviewed studies, is aiming to revolutionise wound care.

Bosque shares the significance of clinical evidence in driving medical advancements and the role of real-world evidence in reflecting true patient experiences.

Learn about the challenges of treating venous leg ulcers and how Aroha’s Endoform product is making a difference by healing wounds faster than traditional methods.

Watch the video to deep dive into the future of regenerative medicine and its impact on patients and the healthcare system.

This video was developed in collaboration with Aroa Biosurgery , a Stockhead client at the time of publishing.

The interviews and discussions in this video are opinions only and not financial or investment advice. Viewers should obtain independent advice based on their own circumstances before making any financial decisions.